| FDA | Food & Drug Administration |
|---|---|
| FDA | fluorescein diacetate; Food and Drug Administration; right frontoanterior [position of the fetus] |
| ODE | Office of Device Evaluation [of FDA] |
| CCHP | Consumer Choice Health Plan |
| CPSC | congenital paucity of secondary synaptic clefts [syndrome]; Consumer Products Safety Commission |
| CAHPS | Consumer Assessment of Health Plan Study |
|---|---|
| CPSC | Consumer Product Safety Commission |
| DTC | Direct to consumer |
| C-FDA | Carboxy-fluorescein-diacetate |
| FDAMA | FDA Modernization Act of 1997 |
| FDA | The U.S. Agency responsible for regulation of biotechnology foodproducts. The major laws under which the agency has regulatory powersinclude the Food, Drug, and Cosmetic act, and the Public Health Service Act. (09 Oct 1997) |
|---|---|
| consumer advocacy | The promotion and support of consumers' rights and interests. (12 Dec 1998) |
| consumer organizations | Organised groups of users of goods and services. (12 Dec 1998) |
| consumer participation | Community or individual involvement in the decision-making process. (12 Dec 1998) |
| consumer satisfaction | Customer satisfaction or dissatisfaction with a benefit or service received. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|